Beth Rogozinski’s Post

View profile for Beth Rogozinski, graphic

Chief Executive Officer at Oncoustics

I <3 Jon Campbell takeaways and agree completely! I'll also add that, regardless of commercial failures in the space, #digital #medicine is here to stay and is really the only hope we have of fixing a broken healthcare system. Additionally, we'll see #AI/ML increasingly being utilized in healthcare to advance early access and equity and improve outcomes.

View profile for Jon Campbell, graphic

Chief Science Officer for the National Pharmaceutical Council

It's been a great week at #BIO2024 in San Diego! On Monday afternoon, I was honored to join a panel discussion on digital therapeutics alongside Brigit Kyei-Baffour, MBA, Chris Koch (LeGen Medical Device LLC), Beth Rogozinski, and Dirk Soenksen.   Two takeaways from our session:  1. We're living in a golden age of innovation, and innovative payment mechanisms are needed for appropriate access to digital technology.  2. Quality evidence on effectiveness, total cost of care, and other benefits and impacts of digital technologies are helpful along the path toward coverage and access. For those attending the BIO International Convention, don't miss John O'Brien's session this afternoon on #PDABs and the #IRA. So many great insights still to come!

To view or add a comment, sign in

Explore topics